New York, July 19, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Infusion Pumps and Devices: Technologies and Global Markets" - https ...
An international, multisite phase 3 trial co-led by a University of Cincinnati researcher found Parkinson’s disease medication delivered through an infusion pump is safe and effective at reducing ...
A therapy for Parkinson’s disease that can be delivered by a 24-hour subcutaneous infusion pump has been recommended for use by the NHS and could be an option for hundreds of patients with the ...
The Department of Health and the Welsh Assembly Government have asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a multiple technology appraisal of ...
Global, multicenter phase 3 study, co-led by a University of Cincinnati expert, confirms the safety and efficacy of administering Parkinson’s medication via infusion pumps for prolonged symptom relief ...
The Infusion Pumps Market has witnessed substantial growth in recent years, fueled by advancements in healthcare technology, a growing prevalence of chronic diseases, and an increasing aging ...
An international, multisite phase 3 trial co-led by a University of Cincinnati researcher found Parkinson’s disease medication delivered through an infusion pump is safe and effective at reducing ...
NEWARK, Del, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The infusion pump market is expected to reach US$ 641.7 million by 2023, putting it on the verge of a significant valuation. The expansion is principally ...
The infusion pumps market is expected to grow significantly, with a projected valuation of US$ 641.7 million by 2023. The market exhibits a noteworthy pattern, with a compound annual growth rate (CAGR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback